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Abstract
Mounting evidence suggests that Q-fever is more prevalent in Iran than originally believed.
However, in most parts of the country, clinicians do not pay enough attention to Q fever in
their differential diagnosis. The aim of this study was to investigate the prevalence of Cox-
iella burnetii in suspected cases of acute Q fever in north-western Iran using molecular tech-
niques. Febrile patients were enrolled in the study and investigated for C. burnetii infection.
Sera samples were tested using real-time PCR for detection of IS1111 gene, and positive
samples were confirmed with nested PCR. Nine patients (4.2%) out of 216 suspected cases
were positive for C. burnetii. Weakness and fatigue, headache, and lethargy were the most
prevalent clinical symptoms in acute Q fever patients. According to the results of this study
and other reports of human cases in Iran, the diagnosis system of Q fever in Iran should be
urgently revamped.
Author summary
Q fever is a zoonotic infectious disease caused by Coxiella burnetii. Domestic ruminants
are the most common source of human infection. Main route of transmission to humans
is inhalation of infected aerosols and dust with C. burnetii. Acute Q fever is usually pre-
sented as a non-specific febrile and self-limiting influenza-like illness, but in severe acute
cases, may manifest as atypical pneumonia or hepatitis. In Iran, Q fever is an endemic dis-
ease with high seroprevalence among humans and domestic animals. However, human Q
fever cases remain undiagnosed in most regions of Iran, especially because most clinicians
fail to spot this disease in their differential diagnosis. The aim of this study was to investi-
gate the prevalence of acute Q fever in suspected cases (216 suspected cases) using molec-
ular techniques. Nine acute Q fever patients were diagnosed by Real-time PCR and
Nested PCR. Weakness and fatigue, headache, and lethargy were the most prevalent clini-
cal symptoms in positive cases. Human Q fever cases described in this, and previous
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Introduction
Q fever is a zoonotic infectious disease caused by Coxiella burnetii, an obligate intracellular
bacterium. Outbreaks have been reported in both developing and developed countries.
Domestic ruminants (cattle, sheep, and goats) are the most common source of human infec-
tion [1]. In animals, C. burnetii infection is mostly asymptomatic, but can lead to abortion,
stillbirth, infertility, endometritis and metritis. Infected animals shed C. burnetii in urine,
feces, milk, and especially in birth or abortion products. Main route of transmission to humans
is inhalation of infected aerosols and dust with C. burnetii. Ingestion of contaminated raw
milk and dairy products, skin or mucosal contact, tick bites, blood transfusion, sexual trans-
mission, and embryo transfer are less common routes of infection transmission to humans [1,
2].
In humans, the incubation period for primary infection has been estimated to be between 7
and 32 days after exposure [3]. Acute Q fever is the primary form of infection by C. burnetii,
and more than half of the patients are asymptomatic. Acute Q fever usually presents itself as a
non-specific febrile self-limiting influenza-like illness, but may also manifest as atypical pneu-
monia or hepatitis [4]. Cardiac involvement, neurological signs, acute lymphadenitis, chole-
cystitis, autoimmunity, bone marrow involvement, and dermatological signs have also been
reported in some acute cases of Q fever [1]. The main manifestation of chronic Q fever is life-
threatening endocarditis and vascular infection. Other less common forms of chronic Q fever
includes abortion, lymphadenitis, osteomyelitis, prosthetic joint arthritis and osteoarticular
infection [1, 5].
Due to the wide range of clinical symptoms of Q fever in humans, clinical diagnosis of the
disease can be challenging based on symptoms alone. Therefore, laboratory confirmation is a
major and crucial part in the diagnosis of clinical cases [4]. Laboratory diagnosis of Q fever in
humans is mainly based on serological tests, ELISA and IFA as the gold standard test. C. burne-
tii isolation from clinical samples is not performed in most diagnostic laboratories because it
requires eukaryotic cell cultures and access to BSL3 facilities. In recent years, PCR-based
molecular assays were developed to detect C. burnetii in clinical specimens. PCR-based tech-
niques are more adapted than serology for early diagnosis of acute Q fever because of delay in
the antibody response, which is detectable only after 2–3 weeks following infection [1, 6].
In Iran, Q fever is an endemic disease with high seroprevalence among humans and domes-
tic animals [7]. In recent years, many acute and chronic Q fever cases have been reported in
Iran [8–11]. Furthermore, several investigations have been published on the prevalence of Q
fever among domestic livestock in Iran [7]. However, human cases of Q fever remain undiag-
nosed in most regions of Iran, especially because most clinicians do not consider this disease
in their differential diagnosis.
The incidence of acute Q fever is underestimated in most parts of the world. The clinical
presentations in acute Q fever patients is very pleomorphic, nonspecific and confusing. Less
than 4% of patients with acute fever require hospitalization [1, 12]. This disease is often disre-
garded by physicians and healthcare system and diagnosis relies upon the physicians’ aware-
ness of the clinical symptoms of acute Q fever and access to reliable diagnostic laboratory
facilities including serology and PCR [4]. Diagnosed acute cases with C. burnetii must be
treated promptly to avoid to chronic Q fever [13]. The rapid and timely diagnosis of acute
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fever can help cure patients and avoid the spreading of the disease. Conducting molecular
studies, such as the current study, can help to rapidly diagnosis of patients with acute febrile ill-
ness, as well as can raise awareness and sensitivity of clinicians and the health care system
about Q fever in Iran. The aim of this study was to investigate the prevalence of C. burnetii in
suspected cases of acute Q fever by molecular methods.
Material and methods
Study design
The samples of this study were collected from two surveys carried out in Tabriz County in the
East Azerbaijan Province (North West of Iran) in 2013 and Ghaemshahr County in the
Mazandaran province (Northern Iran) in 2015–2016.
Sampling
Patients which met the following criteria, were enrolled to the study as suspected acute Q fever
cases:
A. Clinical symptoms: Febrile patients (acute undifferentiated febrile illnesses) had acute
lower respiratory infection (atypical pneumonia) with at least two other symptoms includ-
ing chills, headache, fatigue, shortness of breath, and myalgia, for which the causative
agents were not identified.
B. Epidemiologic Evidence: (1) high-risk occupations (farmers, livestock farm workers, butch-
ers, veterinarians, and laboratory personnel), (2) A history of keeping livestock and pet’s
animals in recent months, or (3) residency in rural regions and/or living in close proximity
(less than 1 km) to livestock farms (cattle, sheep and goats).
Suspected patients were examined by clinical practitioners, and all the symptoms were diag-
nosed by them. The clinical symptoms and epidemiological evidences were recorded by practi-
tioners in the questionnaires. Eligible individuals were selected by the practitioners and
enrolled to the study based on the inclusion criteria. Demographic characteristics, clinical
signs and risk factors were recorded for each participant by a standardized questionnaire
developed for this study (S1 Questionnaire). Blood sample was taken from each patient. Sera
were subsequently extracted and used for molecular investigation.
Ethics statement
This study was approved by the Ethics Committee for Biomedical Research of Tarbiat Mod-
arres University (Ethic Code: IR.TMU.REC.1395.510). The Ethics Committee for Biomedical
Research of Tarbiat Modarres University approved the consent procedure, the proposal and
protocol of this study, covering all the samples taken (blood), questionnaire and verbal or writ-
ten informed consent. All participants signed an informed consent: Written informed consent
was obtained from adult’s patients and parents of patients below the age of 18. Also, for partici-
pants who were illiterate, the consent form was read aloud to them and the interviewer signed
the consent form with the permission of these individuals on their behalf.
C. burnetii Detection
A 200 μL aliquot of each serum was used for DNA extraction. Genomic DNA was isolated
using the Roche High Pure PCR Template Preparation Kit (Roche, Germany), according to
the manufacturer’s instruction.
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All samples were tested by real-time PCR for detection of IS1111 gene of C. burnetii, and
positive samples were confirmed with nested PCR (Table 1). Real-time PCR was performed
using specific primers and probe sequences targeting IS1111 gene (Table 1). Real-time PCR
reactions were performed using the following reaction mixture: 10 μL of 2x RealQ Plus Master
Mix for Probe (Ampliqon, Denmark), 900 nM forward primer, 900 nM reverse primer, 200
nM probe and 4 μL of DNA template. Real-time PCR was performed on the Corbett 6000
Rotor-Gene system (Corbett, Victoria, Australia), with a final volume of 20 μL for each reac-
tion. The PCR amplification program were 10 mins at 95˚C, followed by 45 cycles of 15 s at
94˚C and 60 s at 60˚C [14].
Nested PCR method was performed via two runs of PCR using two sets of primers includ-
ing Trans1 and Trans2 for first amplification followed by 261F and 463R for second amplifica-
tion reaction. The products of first PCR were separately used as DNA template in a second
round of PCR. Each PCR reaction contained 5μL of DNA, 12.5μL Taq DNA Polymerase Mas-
ter Mix RED (Ampliqon, Denmark), and 10 pmol/μL from each primer in a final volume of
25μL. PCR was performed in a thermal cycler (Bioneer, South Korea). The first amplification
of PCR was done at 95˚C for 2 min, followed by five cycles at 94˚C for 30 s, 66 to 61˚C (touch-
down assay) for 1 min and 72˚C for 1 min. These cycles were followed by 35 cycles consisting
of 94˚C for 30 s, 61˚C for 30 s, and 72˚C for 1 min, then a final extension step of 10 min at
72˚C. In the second amplification, the cycling conditions included an initial denaturation of
DNA at 94˚C for 3 min, followed by 35 cycles at 94˚C for 30 s, 50˚C for 45 s, 72˚C for 1 min,
then a final extension step of 10 min at 72˚C. The amplicons were electrophoresed on 1.5%
agarose gel and visualized under UV light [10].
Results
In total, 8500 patients were invited to participate in the study and were screened by the clinical
practitioners; among them 235 patients had the clinical and epidemiological sings to be sus-
pected for Acute Q fever as the discussed inclusion criteria. Participants who matched the
inclusion criteria were selected randomly. Finally, 216 out of 235 suspected febrile patients
were enrolled (138 patients from Tabriz County in East Azerbaijan Province and 78 patients
from Ghaemshahr County in Mazandaran Province) (S1 Fig). The age of participants ranged
between 2–82 years with a mean age of 41.5. In total, 61.1% of individuals were male and
38.9% were female. Residency in rural and urban regions among participants was 60.1% and
39.9%, respectively. Also, 61.6% of participants had a history of keeping domestic animals
(Table 2).
Nine patients’ samples (4.2%) were positive for C. burnetii. All nine sera samples were posi-
tive by nested PCR and real-time PCR (Table 3). Prevalence of acute Q fever in Tabriz County
and Ghaemshahr County were 3.6% and 5.1%, respectively. Weakness and fatigue (100%),
Table 1. Primer sequences for diagnosis of C. burnetii IS1111 gene by nested PCR and real-time PCR.
Protocol Primer Name Sequence (5!3) Amplicon size (bp)
Trans-PCR Trans1 TATGTATCCACCGTAGCCAGTC 687
Trans2 CCCAACAACACCTCCTTATTC
Nested PCR 261F GAGCGAACCATTGGTATCG 203
463R CTTTAACAGCGCTTGAACGT




Diagnosis of Coxiella burnetii in acute febrile illnesses by molecular methods
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007181 February 11, 2019 4 / 9
headache (88. 9%), and lethargy (66.7%) were the most prevalent clinical symptoms in positive
cases (Table 4). Seven (77. 8%) of nine identified patients had a history of keeping livestock.
Also, Seven (77. 78%) of the nine detected acute Q fever cases were female and five (55.5%)
were residents in rural areas. The demographic and epidemiological findings and were not sta-
tistically significant risk factors for Q fever infection.
Discussion
This study is the first molecular investigation of human Q fever cases in the north and north-
west of Iran. Among 216 investigated febrile patients in this study, 4.2% were confirmed to be
infected with C. burnetii. Based on recent evidence, Q fever shows high prevalence in livestock
and milk and also a high seroprevalence in many different human populations in Iran. The
seroprevalence of IgG phase I and II antibodies of Q fever in human has been reported to be
19.80% and 32.86%, respectively. Also, the prevalence of C. burnetii antibodies in goat, sheep
Table 2. Demographic categorization of participants in this study.
Variable Total (%)
N = 216
Acute Q fever Cases (%)
N = 9
Age (years) Under 15 16 (7.4) 1 (11.1)
15–30 48 (22.2) 2 (22.2)
31–45 61 (28.2) 2 (22.2)
46–60 64 (29.7) 1 (11.1)
Over 60 27 (12.5) 3 (33.3)
Gender Female 84 (38.9) 5 (55.5)
Male 132 (61.1) 4 (45.5)
Location Rural 130 (60.1) 2 (22.2)
Urban 86 (39.9) 7 (77.8)
History of domestic animal keeping No 83 (38.4) 1 (11.1)
Yes 133 (61.6) 8 (88.9)
https://doi.org/10.1371/journal.pntd.0007181.t002











1 11/Male Rural Student Headache, Lethargy, Chest Pain, Weakness and Fatigue, Atypical Pneumonia Positive Positive
2 47/Male Rural Farmer Headache, Chest Pain, Cough, Weakness and Fatigue, Myalgia, shortness of
Breath, Arthralgia
Positive Positive
3 20/Male Rural Farmer Headache, Lethargy, Chest Pain, Cough, Weakness and Fatigue, Myalgia,
Shortness of Breath, Arthralgia, Atypical Pneumonia
Positive Positive
4 40/Male Rural Farmer Headache, Chest Pain, Weakness and Fatigue, Arthralgia Positive Positive
5 32/
Female
City Housekeeper Headache, Lethargy, Weakness and Fatigue, Shortness of Breath Positive Positive
6 28/
Female





City Housekeeper Lethargy, Weakness and Fatigue, Myalgia Positive Positive
8 74/
Female
Rural Housekeeper Headache, Lethargy, Weakness and Fatigue, Myalgia, Arthralgia Positive Positive
9 68/
Female
Rural Housekeeper Headache, Weakness and Fatigue, Myalgia, Arthralgia Positive Positive
https://doi.org/10.1371/journal.pntd.0007181.t003
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and cattle were reported to be 31.97%, 24.66% and 13.30%, respectively [7]. Despite all evi-
dence, the disease is underestimated by clinicians and the health system in Iran. In fact, most
of the clinically diagnosed cases of Q fever have been the outcome of research projects. The
results of this study and other reports about human cases in Iran, suggest that the physicians
and health care system should pay more attention to diagnosis of Q fever cases in Iran. Special
training should be provided for diagnosis of Q fever for clinicians and infectious diseases spe-
cialists. In addition to these measures, laboratory diagnostic facilities for the diagnosis of C.
burnetii infection should be expanded throughout the country. It is essential that the health-
care system provides the necessary training for people to understand the disease and to prevent
it. Patients with suspected clinical symptoms of acute Q fever must be advised to follow up on
specific tests as well as on the completion of appropriate treatment. This way, a higher number
of suspected Q fever patients will be diagnosed and treated and thus prevent possible progres-
sion of the disease toward chronic Q fever. It is noteworthy that all patients in our study diag-
nosed with acute Q fever were treated with appropriate antibiotics (Doxycycline and
Hydroxychloroquine) and all effectively recovered.
In this study, 4.2% of the 216 suspected febrile patients were positive for IS1111 gene of C.
burnetii as confirmed by nested PCR and real-time PCR. Prevalence of acute Q fever in Tabriz
county (East Azarbaijan province) and Ghaemshahr county (Mazandaran province) were
3.6% and 5.3%, respectively. In a similar study that was conducted in northeastern Iran, 7.4%
of 92 patients were positive for C. burnetii, as confirmed by nested PCR [10]. In similar studies
conducted in other countries; molecular prevalence of C. burnetii in acute febrile patients were
0.4% in Senegal [15], 4.5% in India [16] and 14.1% in Poland [17]. The low molecular preva-
lence of acute Q fever in febrile cases in our study compared to other studies may be due to a
number of factors, such as differences in geographical location and climate. More comprehen-
sive studies in this region and other regions of Iran can be helpful for accurate estimation of
the C. burnetii infection in acute illness.
Table 4. Descriptive analysis of clinical signs among participants in the study.
Clinical symptoms Number of patients (% positive cases)
Headache Yes 176 (4.54)
No 27 (3.7)
Lethargy Yes 111 (5.4)
No 92 (3.26)
Chest pain Yes 96 (5.21)
No 107 (3.74)
Cough Yes 73 (4.11)
No 130 (4.61)
Weakness and fatigue Yes 173 (5.2)
No 30 (0)
Diarrhea Yes 17 (5.88)
No 186 (4.3)
Myalgia Yes 158 (3.16)
No 45 (8.89)
Pneumonia Yes 89 (3.37)
No 114 (5.26)
Shortness of breath Yes 68 (4.11)
No 135 (4.44)
https://doi.org/10.1371/journal.pntd.0007181.t004
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Acute Q fever generally presents as a flu-like illness with wide range of nonspecific clinical
manifestations [4]. Patients with cute Q fever may develop respiratory illness or hepatitis.
Pneumonia is an important clinical manifestation of acute Q fever, and C. burnetii might be an
underrecognized cause of community-acquired pneumonia [13, 15]. Based on available infor-
mation and review of the literature, most clinical data of acute Q fever were obtained from
patients with Q fever pneumonia [1, 4, 14, 18–20]. Due to the above reasons, we enrolled acute
febrile patients with pneumonia (acute lower respiratory tract infections). For future studies, it
is recommended that a wider range of clinical symptoms along with pneumonia and undiffer-
entiated fever be considered in order to cast a wider net for the diagnosis of the clinical cases
of acute Q fever.
Serologic tests are known as reference methods for diagnosis of clinical cases of Q fever.
The reason for the use of serology as detection method is partially the limitation of culture
methods in isolation of C. burnetii and also the strong immune response to the infection (the
antibody produced against the bacterium) in the human body, which is easily detectable by
serological tests [13]. Unfortunately, serology has limitations in diagnosis of acute febrile ill-
nesses, because it requires two serum specimens (from the acute phase and the convalescent
period) and looks for a fourfold increase in antibody content in paired serum samples. Access
to the second serum sample takes time (approximately 4 weeks) [4]. Molecular tests are an
attractive alternative; they allow for rapid, one-step, diagnosis of patients with acute Q fever
and can be performed at an early stage of the C. burnetii infection [1, 14]. In our study, we
developed a diagnostics assay based on real-time PCR for diagnosis of suspected patients and
we used nested PCR for confirmation of positive results by Real time-PCR. All nine positive
cases were confirmed with nested PCR. Employing this laboratory diagnostic protocol (real-
time PCR) can improve and accelerate primary molecular detection, after which the initial
positive results can be confirmed by the nested PCR. It is worth noting that the initial and con-
firmation tests identify and amplify different regions of the IS1111 gene of C. burnetii, increas-
ing the fidelity of the detection technique. Based on our results, we recommend that molecular
tests be combined with the accepted serological tests to diagnose patients with suspected Q
fever in shorter time and at earlier stages of the disease.
One of the limitations of our study was the small number of positive cases, which made us
unable to do a proper statistical analysis of risk factors and epidemiologic factors. In addition,
more precision in the entry of eligible individuals and those who were more closely related to
the criteria for diagnosis of acute Q fever, could provide a more precise prevalence of acute Q
fever. The combination of molecular tests with serologic tests (as the gold standard diagnostics
method) allows for proper identification of all suspected patients. Another limitation of our
study was lack of attention to whether antibiotics against C. burnetii were administered during
the sampling time. Therefore, it is suggested that the mentioned limitations should be consid-
ered in subsequent studies.
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